Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 950 of 1294 entries
View as:

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NNC0148-0000-0287 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01809184 Org: User:
Start: 03/04/13 End: 09/06/13 Due: 09/06/14

A Research Study About Weight Loss and Treatment Patterns With the Use of Saxenda® in Adults in Real-life Settings in Switzerland

Phase: N/A Priority: Normal
NCT ID: NCT05153590 Org: User:
Start: 12/03/21 End: 04/15/22 Due: 04/15/23

A Trial Investigating NN1218 in Subjects With Type 1 and Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01121276 Org: User:
Start: 04/30/10 End: 09/30/10 Due: 09/30/11

Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01507337 Org: User:
Start: 04/30/04 End: 06/30/04 Due: 06/30/05

Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015

Phase: N/A Priority: Normal
NCT ID: NCT00984126 Org: User:
Start: 10/26/09 End: 06/29/16 Due: 06/29/17

Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol

Phase: N/A Priority: Normal
NCT ID: NCT04682145 Org: User:
Start: 12/09/20 End: 04/01/25 Due: 04/01/26

Comparison of the Blood Sugar Lowering Effect Between Repaglinide Plus Metformin and Repaglinide Alone in Type 2 Diabetics Not Previously Treated With Oral Sugar-lowering Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00819741 Org: User:
Start: 02/28/09 End: 11/30/09 Due: 11/30/10

Efficacy and Safety of Levemir® Used as Basal Insulin

Phase: N/A Priority: Normal
NCT ID: NCT01548248 Org: User:
Start: 01/31/06 End: 10/31/06 Due: 10/31/07

Diabetes Attitudes Wishes and Needs

Phase: N/A Priority: Normal
NCT ID: NCT01507116 Org: User:
Start: 03/31/12 End: 09/30/12 Due: 09/30/13

Comparison of Insulin Degludec With Insulin Glargine in Subjects With Type 1 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01868529 Org: User:
Start: 01/31/08 End: 06/30/08 Due: 06/30/09

A Trial Investigating the Effect of NN1250 in Japanese Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01135927 Org: User:
Start: 06/30/10 End: 10/31/10 Due: 10/31/11

Comparison of Insulin Detemir and NPH With Respect to Lowering the Blood Sugar and Symptoms Experienced by Type 1 Diabetics During Hypoglycaemia

Phase: N/A Priority: Normal
NCT ID: NCT00760448 Org: User:
Start: 04/30/04 End: 10/31/05 Due: 10/31/06

Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00687063 Org: User:
Start: 04/30/08 End: 02/28/09 Due: 02/28/10

Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

Phase: N/A Priority: Normal
NCT ID: NCT01900834 Org: User:
Start: 07/31/13 End: 10/31/15 Due: 10/31/16

Switching From Insulin Glargine to Insulin Degludec in Subjects With Type 2 Diabetes Mellitus (BEGIN™)

Phase: N/A Priority: Normal
NCT ID: NCT01135992 Org: User:
Start: 06/30/10 End: 11/30/10 Due: 11/30/11

Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01709929 Org: User:
Start: 10/31/05 End: 04/30/06 Due: 04/30/07

Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00282451 Org: User:
Start: 02/28/06 End: 08/31/06 Due: 08/31/07

Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

Phase: N/A Priority: Normal
NCT ID: NCT00791895 Org: User:
Start: 06/26/03 End: 11/29/04 Due: 11/29/05

A Research Study Looking Into Blood and Urine Levels of the Medicine NNC0194-0499 in the Body and How Well it is Tolerated in Participants With Reduced Kidney Function and Normal Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT05727644 Org: User:
Start: 02/15/23 End: 11/10/23 Due: 11/10/24

A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT02382939 Org: User:
Start: 02/12/15 End: 01/04/16 Due: 01/04/17

A Research Study of How NNC0174-0833 Behaves in Japanese and Caucasian Volunteers Who Are Normal Weight, Overweight or With Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03787225 Org: User:
Start: 01/07/19 End: 06/04/19 Due: 06/04/20

Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00793273 Org: User:
Start: 11/30/08 End: 01/31/11 Due: 01/31/12

Efficacy and Safety of Insulin Detemir in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00595374 Org: User:
Start: 12/02/03 End: 10/07/04 Due: 10/07/05

A Research Study Looking at How a Single Dose of the Medicine NNC0194-0499 Behaves in Chinese Men

Phase: N/A Priority: Normal
NCT ID: NCT05742919 Org: User:
Start: 02/16/23 End: 06/13/23 Due: 06/13/24

Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00280046 Org: User:
Start: 11/30/03 End: 07/31/04 Due: 07/31/05